Literature DB >> 16368099

Increased atherosclerotic lesion area in apoE deficient mice overexpressing bovine growth hormone.

Irene J Andersson1, Anna Ljungberg, Lennart Svensson, Li-Ming Gan, Jan Oscarsson, Göran Bergström.   

Abstract

Human growth hormone (GH) excess is linked to increased cardiovascular morbidity and mortality. However, little is known about the effect of GH excess on atherosclerosis. We developed a new mouse model to assess the hypothesis that GH overexpression accelerates atherosclerotic lesion formation. apoE(-/-) mice were crossed with bovine GH (bGH) transgenic mice to yield apoE(-/-) mice overexpressing bGH (apoE(-/-)/bGH). The mice were fed either standard or Western diet. At 22 weeks, atherosclerotic lesion area of thoracic aorta was larger in apoE(-/-)/bGH mice compared with littermate apoE(-/-) mice fed either diet (standard: +161+/-50%, Western: +430+/-134%). Aortic sinus lesions were more severe in apoE(-/-)/bGH mice fed standard diet compared with littermate apoE(-/-) mice. apoE(-/-)/bGH mice had lower (VLDL+LDL)/HDL ratios compared with littermate apoE(-/-) mice, while systolic blood pressure was higher in apoE(-/-)/bGH mice, irrespective of diet. The levels of serum amyloid A and hepatic CRP mRNA were higher in apoE(-/-)/bGH mice than in littermate apoE(-/-) mice. In conclusion, this study shows that excess GH augments the development of atherosclerosis in apoE(-/-) mice. The mechanisms could be direct effects of GH on cellular processes in the vessel wall or the result of concomitant processes such as hypertension or a general inflammatory state.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16368099     DOI: 10.1016/j.atherosclerosis.2005.11.020

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

1.  Plasma proteomic profiles of bovine growth hormone transgenic mice as they age.

Authors:  Juan Ding; Darlene E Berryman; John J Kopchick
Journal:  Transgenic Res       Date:  2011-03-02       Impact factor: 2.788

2.  Does Apolipoprotein E genotype affect cardiovascular risk in subjects with acromegaly?

Authors:  Vildan Bozok Cetintas; Ayhan Zengi; Asli Tetik; Muammer Karadeniz; Faruk Ergonen; Ali Sahin Kucukaslan; Sadik Tamsel; Buket Kosova; Serap Baydur Sahin; Fusun Saygılı; Zuhal Eroglu
Journal:  Endocrine       Date:  2011-12-27       Impact factor: 3.633

Review 3.  Aging, atherosclerosis, and IGF-1.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Asif Anwar; Shaw-Yung Shai; Patrice Delafontaine
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-05       Impact factor: 6.053

Review 4.  IGF-1, oxidative stress and atheroprotection.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Asif Anwar; Shaw-Yung Shai; Patrice Delafontaine
Journal:  Trends Endocrinol Metab       Date:  2010-01-12       Impact factor: 12.015

5.  Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wall.

Authors:  Amir J Guri; Sarah A Misyak; Raquel Hontecillas; Alyssa Hasty; Dongmin Liu; Hongwei Si; Josep Bassaganya-Riera
Journal:  J Nutr Biochem       Date:  2010-01-25       Impact factor: 6.048

6.  Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/- mice but does not reduce atherosclerosis.

Authors:  Jane S Titterington; Sergiy Sukhanov; Yusuke Higashi; Charlotte Vaughn; Cyril Bowers; Patrice Delafontaine
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

Review 7.  Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging.

Authors:  Yusuke Higashi; Henry C Quevedo; Summit Tiwari; Sergiy Sukhanov; Shaw-Yung Shai; Asif Anwar; Patrice Delafontaine
Journal:  Front Horm Res       Date:  2014-06-10       Impact factor: 2.606

8.  Increased diet-induced fatty streak formation in female mice with deficiency of liver-derived insulin-like growth factor-I.

Authors:  Johan Svensson; Klara Sjögren; Malin Levin; Jan Borén; Åsa Tivesten; Claes Ohlsson
Journal:  Endocrine       Date:  2015-12-01       Impact factor: 3.633

9.  Treatment of growth hormone attenuates hepatic steatosis in hyperlipidemic mice via downregulation of hepatic CD36 expression.

Authors:  Hyung Seok Jang; Kyeongdae Kim; Mi-Ran Lee; Shin-Hye Kim; Jae-Hoon Choi; Mi Jung Park
Journal:  Anim Cells Syst (Seoul)       Date:  2020-06-12       Impact factor: 1.815

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.